๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern Cooperative Oncology Group Study


Book ID
122536549
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
313 KB
Volume
6
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase II study of N-methylformamide, spi
โœ Ettinger, David S. ;Finkelstein, Dianne M. ;Donehower, Ross C. ;Chang, Alex Y. C ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 407 KB

One hundred forty-four patients with non-small cell lung cancer, the majority (72%) of whom had received previous chemotherapy, were evaluable in this randomized phase II study of N-methylformamide (N-MF), spirogermanium, and 4-demethoxydaunorubicin. There were two partial responses, one each with s